Cargando…

KMO in the promotion of tumor development and progression in hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common cancers and an important medical problem with poor prognosis. The role of messenger RNA (mRNA) has been broadly researched in the progression of different human cancers. Microarray analysis has demonstrated that kynurenine 3-monoox...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Jun, Song, Jianping, Zeng, Xinmin, Hu, Yanqin, Kuang, Jingru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186542/ https://www.ncbi.nlm.nih.gov/pubmed/37201083 http://dx.doi.org/10.21037/jgo-23-147

Ejemplares similares

Kynurenine pathway enzyme KMO in cancer progression: A tip of the Iceberg
por: Park, So-Yeon, et al.
Publicado: (2020)

Kynurenine catabolic enzyme KMO regulates HCC growth
por: Shi, Zhaopeng, et al.
Publicado: (2022)

7th International Conference on Knowledge Management in Organizations (KMO)
por: Uden, Lorna, et al.
Publicado: (2013)

The Kynurenine 3-Monooxygenase Encoding Gene, BcKMO, Is Involved in the Growth, Development, and Pathogenicity of Botrytis cinerea
por: Zhang, Kang, et al.
Publicado: (2018)

Inhibition of KMO Ameliorates Myocardial Ischemia Injury via Maintaining Mitochondrial Fusion and Fission Balance
por: Lai, Qiong, et al.
Publicado: (2023)

Altered hippocampal plasticity by prenatal kynurenine administration, kynurenine-3-monoxygenase (KMO) deletion or galantamine
por: Forrest, C.M., et al.
Publicado: (2015)

IL-35 expression in hepatocellular carcinoma cells is associated with tumor progression
por: Long, Jun, et al.
Publicado: (2016)

Hornerin promotes tumor progression and is associated with poor prognosis in hepatocellular carcinoma
por: Fu, Shun-Jun, et al.
Publicado: (2018)

TDO Promotes Hepatocellular Carcinoma Progression
por: Li, Shanbao, et al.
Publicado: (2020)

PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma
por: Leung, Carmen Oi-ning, et al.
Publicado: (2015)

Knowledge management in organizations: 10th international conference, KMO 2015, Maribor, Slovenia, August 24-28, 2015, proceedings
por: Uden, Lorna, et al.
Publicado: (2015)

Knowledge management in organizations: 14th international conference, KMO 2019, Zamora, Spain, July 15-18, 2019, proceedings
por: Uden, Lorna, et al.
Publicado: (2019)

Knowledge management in organizations: 12th international conference, KMO 2017, Beijing, China, August 21-24, 2017, proceedings
por: Uden, Lorna, et al.
Publicado: (2017)

Knowledge management in organizations: 13th international conference, KMO 2018, Žilina, Slovakia, August 6-10, 2018, proceedings
por: Uden, Lorna, et al.
Publicado: (2018)

Knowledge management in organizations: 9th international conference, KMO 2014, Santiago, Chile, September 2-5, 2014, proceedings
por: Uden, Lorna, et al.
Publicado: (2014)

Kynurenine pathway metabolism following prenatal KMO inhibition and in Mecp2(+/−) mice, using liquid chromatography-tandem mass spectrometry
por: Forrest, Caroline M., et al.
Publicado: (2016)

HBx and YAP expression could promote tumor development and progression in HBV-related hepatocellular carcinoma
por: Oda, Chiyumi, et al.
Publicado: (2022)

Validation of Hepatocellular Carcinoma Experimental Models for TGF-β Promoting Tumor Progression
por: Mancarella, Serena, et al.
Publicado: (2019)

RPL19 Is a Prognostic Biomarker and Promotes Tumor Progression in Hepatocellular Carcinoma
por: Rao, Benchen, et al.
Publicado: (2021)

Norcholic Acid Promotes Tumor Progression and Immune Escape by Regulating Farnesoid X Receptor in Hepatocellular Carcinoma
por: Gong, Yihang, et al.
Publicado: (2021)

Na(2.9)KMo(12)S(14): a novel quaternary reduced molybdenum sulfide containing Mo(12) clusters with a channel structure
por: Gougeon, Patrick, et al.
Publicado: (2013)

LncSHRG promotes hepatocellular carcinoma progression by activating HES6
por: Xu, Ying-Chen, et al.
Publicado: (2017)

Upregulation of hsa_circ_0002003 promotes hepatocellular carcinoma progression
por: Zhou, Lisha, et al.
Publicado: (2023)

Sleep Deprivation Disturbs Immune Surveillance and Promotes the Progression of Hepatocellular Carcinoma
por: Huang, Jing, et al.
Publicado: (2021)

The Progress in the Treatment of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
por: Luo, Fangzhou, et al.
Publicado: (2021)

Overexpression of RBM34 Promotes Tumor Progression and Correlates with Poor Prognosis of Hepatocellular Carcinoma
por: Wang, Wei, et al.
Publicado: (2023)

Up-regulation of CDK16 by multiple mechanisms in hepatocellular carcinoma promotes tumor progression
por: Wang, Yitao, et al.
Publicado: (2017)

Upregulation of TMCO3 Promoting Tumor Progression and Contributing to the Poor Prognosis of Hepatocellular Carcinoma
por: Dai, Tianxing, et al.
Publicado: (2022)

Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression
por: Wu, Qin, et al.
Publicado: (2019)

Talin-1 interaction network promotes hepatocellular carcinoma progression
por: Chen, Peng, et al.
Publicado: (2017)

Upregulation of histamine receptor H1 promotes tumor progression and contributes to poor prognosis in hepatocellular carcinoma
por: Zhao, Jing, et al.
Publicado: (2019)

Activated platelets inhibit hepatocellular carcinoma cell differentiation and promote tumor progression via platelet-tumor cell binding
por: Zhang, Rongfeng, et al.
Publicado: (2016)

Evaluation of tumor mutational burden in small early hepatocellular carcinoma and progressed hepatocellular carcinoma
por: Wong, Mary, et al.
Publicado: (2021)

Extracellular matrix collagen I promotes the tumor progression of residual hepatocellular carcinoma after heat treatment
por: Zhang, Rui, et al.
Publicado: (2018)

LPCAT1 overexpression promotes the progression of hepatocellular carcinoma
por: He, Rong-Quan, et al.
Publicado: (2021)

Upregulating KTN1 promotes Hepatocellular Carcinoma progression
por: Pan, Jian, et al.
Publicado: (2021)

Overexpression of semaphorin 3A promotes tumor progression and predicts poor prognosis in hepatocellular carcinoma after curative resection
por: Hu, Zhi-Qiang, et al.
Publicado: (2016)

Lipid Metabolism in Development and Progression of Hepatocellular Carcinoma
por: Sangineto, Moris, et al.
Publicado: (2020)

TMED3 promotes the progression and development of lung squamous cell carcinoma by regulating EZR
por: Xie, An, et al.
Publicado: (2021)

MCT4 Promotes Hepatocellular Carcinoma Progression by Upregulating TRAPPC5 Gene
por: Niu, Zheyu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h6u5ge7haa0oo44dsdcm23kr5c